Status:
RECRUITING
Treating Amblyopia With CureSight
Lead Sponsor:
Alaska Blind Child Discovery
Conditions:
Amblyopia
Eligibility:
All Genders
2-20 years
Phase:
NA
Brief Summary
Patients with visual acuity and ocular characteristics outside the Novasight FDA multi-center study are to perform the same Curesight procedures- including M\&S EVA or eETDRS patched acuity, stereo an...
Detailed Description
Patients with visual acuity worse than 20/30 due to amblyopia will be offered therapy with Curesight. The Curesight-component of amblyopia therapy will be offered no-charge for up to 4 months. The Cur...
Eligibility Criteria
Inclusion
- amblyopia
Exclusion
- lack of brain and eye capacity for improved vision lack of home WiFi
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06165705
Start Date
March 1 2023
End Date
December 31 2025
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alaska Blind Child Discovery
Anchorage, Alaska, United States, 99508